A novel vaccine delivery system using immunopotentiating fusogenic liposomes

被引:28
作者
Hayashi, A
Nakanishi, T
Kunisawa, J
Kondoh, M
Imazu, S
Tsutsumi, Y
Tanaka, K
Fujiwara, H
Hamaoka, T
Mayumi, T
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Osaka 5650871, Japan
[2] Osaka Univ, Sch Med, Biomed Res Ctr, Osaka 5650871, Japan
关键词
fusogenic liposome; ovalbumin; nonreplicating vaccine; humoral immunity; Sendai virus;
D O I
10.1006/bbrc.1999.1044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported the preparation and characterization of fusogenic liposomes (FLs), which have two highly immunogenic glycoproteins of the Sendai virus on their surface. In this report, we investigated the capacity of FLs to enhance antigen-specific humoral immunity in mice. FLs function as a lymphocyte mitogen with high immunogenicity consistent with viral envelope proteins. Markedly increased levels of anti-ovalbumin (OVA) antibody were detected in serum from mice immunized with OVA encapsulated in FLs compared to sera from mice immunized with free OVA or OVA encapsulated in plain liposomes. An anti-OVA antibody response was not observed in mice immunized with OVA simply mixed with empty FLs. These results indicate that FLs function as a novel immunoadjuvant in inducing antigen-specific antibody production. (C) 1999 Academic Press.
引用
收藏
页码:824 / 828
页数:5
相关论文
共 27 条
[1]   LONG-TERM MORTALITY FOLLOW-UP OF ARMY RECRUITS WHO RECEIVED ADJUVANT INFLUENZA-VIRUS VACCINE IN 1951-1953 [J].
BEEBE, GW ;
SIMON, AH ;
VIVONA, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1972, 95 (04) :337-&
[2]   FUNCTIONAL-ACTIVITY INVIVO OF EFFECTOR T-CELL POPULATIONS .3. PROTECTION AGAINST MOLONEY MURINE SARCOMA-VIRUS (M-MSV)-INDUCED TUMORS IN T-CELL DEFICIENT MICE BY THE ADOPTIVE TRANSFER OF A M-MSV-SPECIFIC CYTOLYTIC LYMPHOCYTE-T CLONE [J].
CERUNDOLO, V ;
LAHAYE, T ;
HORVATH, C ;
ZANOVELLO, P ;
COLLAVO, D ;
ENGERS, HD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (02) :173-178
[3]   HIV PREVENTIVE VACCINES - PROGRESS TO DATE [J].
ESPARZA, J ;
OSMANOV, S ;
HEYWARD, WL .
DRUGS, 1995, 50 (05) :792-804
[4]  
FLEHMIG B, 1989, LANCET, V1, P1039
[5]  
FREUND J, 1951, AM J CLIN PATHOL, V21, P645
[6]  
FUKUDA S, 1988, LYMPHOKINE RES, V7, P175
[7]   THE INS AND OUTS OF ANTIGEN PROCESSING AND PRESENTATION [J].
GERMAIN, RN .
NATURE, 1986, 322 (6081) :687-689
[8]   IMMUNOPOTENTIATING RECONSTITUTED INFLUENZA-VIRUS VIROSOME VACCINE DELIVERY SYSTEM FOR IMMUNIZATION AGAINST HEPATITIS-A [J].
GLUCK, R ;
MISCHLER, R ;
BRANTSCHEN, S ;
JUST, M ;
ALTHAUS, B ;
CRYZ, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (06) :2491-2495
[9]   THE REAL DIFFICULTIES FOR MALARIA SPOROZOITE VACCINE DEVELOPMENT - NONRESPONSIVENESS AND ANTIGENIC VARIATION [J].
GOOD, MF ;
KUMAR, S ;
MILLER, LH .
IMMUNOLOGY TODAY, 1988, 9 (11) :351-355
[10]   ADJUVANTS FOR HUMAN VACCINES - CURRENT STATUS, PROBLEMS AND FUTURE-PROSPECTS [J].
GUPTA, RK ;
SIBER, GR .
VACCINE, 1995, 13 (14) :1263-1276